HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Presentation of peptides from Bacillus anthracis protective antigen on Tobacco Mosaic Virus as an epitope targeted anthrax vaccine.

Abstract
The current anthrax vaccine requires improvements for rapidly invoking longer-lasting neutralizing antibody responses with fewer doses from a well-defined formulation. Designing antigens that target neutralizing antibody epitopes of anthrax protective antigen, a component of anthrax toxin, may offer a solution for achieving a vaccine that can induce strong and long lasting antibody responses with fewer boosters. Here we report implementation of a strategy for developing epitope focused virus nanoparticle vaccines against anthrax by using immunogenic virus particles to present peptides derived from anthrax toxin previously identified in (1) neutralizing antibody epitope mapping studies, (2) toxin crystal structure analyses to identify functional regions, and (3) toxin mutational analyses. We successfully expressed two of three peptide epitopes from anthrax toxin that, in previous reports, bound antibodies that were partially neutralizing against toxin activity, discovered cross-reactivity between vaccine constructs and toxin specific antibodies raised in goats against native toxin and showed that antibodies induced by our vaccine constructs also cross-react with native toxin. While protection against intoxication in cellular and animal studies were not as effective as in previous studies, partial toxin neutralization was observed in animals, demonstrating the feasibility of using plant-virus nanoparticles as a platform for epitope defined anthrax vaccines.
AuthorsRyan C McComb, Chi-Lee Ho, Kenneth A Bradley, Laurence K Grill, Mikhail Martchenko
JournalVaccine (Vaccine) Vol. 33 Issue 48 Pg. 6745-51 (Nov 27 2015) ISSN: 1873-2518 [Electronic] Netherlands
PMID26514421 (Publication Type: Journal Article)
CopyrightCopyright © 2015 Elsevier Ltd. All rights reserved.
Chemical References
  • Anthrax Vaccines
  • Antibodies, Bacterial
  • Antibodies, Neutralizing
  • Antigens, Bacterial
  • Bacterial Toxins
  • Drug Carriers
  • Epitopes
  • Vaccines, Subunit
  • Vaccines, Synthetic
  • anthrax toxin
Topics
  • Animals
  • Anthrax Vaccines (administration & dosage, genetics, immunology)
  • Antibodies, Bacterial (blood)
  • Antibodies, Neutralizing (blood)
  • Antigens, Bacterial (genetics, immunology)
  • Bacterial Toxins (genetics, immunology)
  • Cross Reactions
  • Drug Carriers
  • Epitopes (genetics, immunology)
  • Female
  • Genetic Vectors
  • Goats
  • Mice, Inbred C57BL
  • Tobacco Mosaic Virus (genetics)
  • Vaccines, Subunit (administration & dosage, genetics, immunology)
  • Vaccines, Synthetic (administration & dosage, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: